Table 4. Prevalence of fecal carriage of resistant Enterobacteriaceae.

Outcome	Control, n/N (%)	Village-wide prophylaxis, n/N (%)	Difference in differences from day 0 (95% CI), p-value
CiproR
Day 0	189/198 (95.5%)	175/185 (94.6%)
Day 7	179/192 (93.2%)	176/181 (97.2%)	4.9 (−1.0 to 10.8), p = 0.11
Day 28	183/193 (94.8%)	178/180 (98.9%)	5.0 (−0.4 to 10.3), p = 0.07
ESBL-producing bacteria
Day 0	181/198 (91.4%)	173/185 (93.5%)
Day 7	167/192 (87.0%)	168/181 (92.8%)	3.8 (−3.8 to 11.3), p = 0.33
Day 28	179/193 (92.7%)	167/180 (92.8%)	−2.0 (−9.0 to 5.0), p = 0.58
CiproR + ESBL-producing bacteria
Day 0	130/196 (66.3%)	122/184 (66.3%)
Day 7	139/192 (72.4%)	150/181 (82.9%)	10.7 (−0.1 to 22.3), p = 0.07
Day 28	139/193 (72.0%)	138/180 (76.7%)	4.7 (−8.1 to 17.5), p = 0.47

CiproR, resistance to ciprofloxacin; ESBL, extended-spectrum beta-lactamase.